Compare HCA Health Inc (HCA) vs Nasdaq Inc (NDAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Nasdaq Inc — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while Nasdaq Inc trades at $89.8 (market cap $51.96B). The key difference: HCA Health Inc is the larger of the two by market cap, and Nasdaq Inc pays the higher dividend (1.22%). Which is the better fit depends on your goals.
| HCA | NDAQ | |
|---|---|---|
Market Cap | $82.17B | $51.96B |
Sector | Health | Financials |
52-Week High | $545.13 | $100.98 |
52-Week Low | $334.32 | $76.85 |
Enterprise Value | $131.08B | $59.02B |
Dividend Yield | 0.84% | 1.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $373.09, up 0.51% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 preliminary revenue above expectations but cut full-year profit guidance, causing recent stock pressure. Analyst consensus remains bullish with a $469.40 price target, though multiple law firms are investigating potential securities law violations following the guidance revision.
Investment outlook balances strong operational performance against near-term headwinds. The stock offers value with a 12.76 P/E ratio and consistent earnings beats, but faces risks from rising expenses, payer mix challenges, and ongoing legal investigations. Institutional sentiment remains positive despite technical weakness and recent guidance concerns.
Nasdaq (NDAQ) trades at $90.24, down 1.53% today, with a bullish technical signal from moving averages and a consensus analyst price target of $107.00. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.96 exceeding expectations, and maintains robust profitability with a net income margin of 23.03%. Recent news highlights strategic growth, including the acquisition of Nasdaq Fund Secondaries by NPM, expanding its platform beyond direct company shares.
The outlook for NDAQ is positive, supported by organic revenue growth and strategic acquisitions, though risks include market volatility and execution challenges. With 61.11% of analysts rating it a buy and a price target implying ~19% upside, the stock presents a growth opportunity for investors focused on financial infrastructure expansion, balanced by monitoring debt levels and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →
